Αποτελέσματα Αναζήτησης
5 Μαΐ 2023 · When new COVID-19 vaccines were first administered two years ago, public health officials found an increase in cases of myocarditis, an inflammation of the heart muscle, particularly among young males who had been vaccinated with mRNA vaccines.
- Q&A: What Causes Rare Instances of Myocarditis After mRNA COVID-19 ...
What is the likelihood of developing myocarditis...
- Q&A: What Causes Rare Instances of Myocarditis After mRNA COVID-19 ...
11 Ιουν 2022 · An increased risk of myocarditis or pericarditis was observed after COVID-19 mRNA vaccination and was highest in men aged 18–25 years after a second dose of the vaccine. However, the incidence was rare.
11 Ιουν 2022 · The absolute risk of myocarditis or pericarditis, calculated as the incidence rate within 1–7 days of vaccination, for men aged 18–25 years after a second vaccination dose was 2·17 (95% CI 1·55–3·04) cases per 100 000 person-days for the Moderna vaccine, mRNA-1273, and 1·71 (1·31–2·23) cases per 100 000 person-days for the Pfizer ...
6 Σεπ 2024 · We included patients ≤30 years of age with a clinical diagnosis of acute myocarditis after COVID-19 vaccination based on clinical presentation, abnormal biomarkers and/or cardiovascular imaging findings.
28 Ιουν 2024 · Available evidence shows that COVID-19 mRNA vaccination is associated with an increased risk of myocarditis, but at a much lower level than the risk associated with COVID-19 infection,...
16 Μαΐ 2023 · What is the likelihood of developing myocarditis post-vaccination, and who is most at risk? Iwasaki: Myocarditis risk depends on the age and sex of the vaccine recipient. It is most common in younger males—adolescents or young adults.
20 Ιουλ 2021 · There is now increasing evidence for myocarditis and myopericarditis as rare complications of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males. Here we provide further details about this phenomenon and its potential underlying mechanisms.
